Carlos Aguado

Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer

Mariano Provencio, Ernest Nadal, J.L. González-Larriba et al. · New England Journal of Medicine · 2023 · 450 citations · Full text

Medicine, Oncology, Surgery +17

Nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage IIIA NSCLC: Primary endpoint results of pathological complete response (pCR) from phase II NADIM II trial.

Mariano Provencio-Pulla, Ernest Nadal, J.L. González-Larriba et al. · Journal of Clinical Oncology · 2022 · 63 citations

Medicine, Oncology, Pharmacology +17

LBA65 KRYSTAL-7: Efficacy and safety of adagrasib with pembrolizumab in patients with treatment-naïve, advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation

Marina Chiara Garassino, Willemijn S.M.E. Theelen, Robert M. Jotte et al. · Annals of Oncology · 2023 · 49 citations · Full text

Medicine, Oncology, Pharmacology +16

High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

Nerea Muñoz-Unceta, Jon Zugazagoitia, Elisabeth Jiménez-Aguilar et al. · European Journal of Cancer · 2020 · 25 citations

Medicine, Cancer Biology, Oncology +14

Fatal Autoimmune Storm After a Single Cycle of Anti-PD-1 Therapy

Jesús Fuentes‐Antrás, Paloma Peinado, Kissy Guevara‐Hoyer et al. · Hematology/Oncology and Stem Cell Therapy · 2020 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17